Web Results

caselaw.findlaw.com/us-supreme-court/09-152.html

United States Supreme Court. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09-152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely ...

law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2014cv08192/433673/50

Neopharm Ltd. et al v. Wyeth-Ayerst International LLC, No. 1:2014cv08192 - Document 50 (S.D.N.Y. 2016) case opinion from the Southern District of New York U.S. Federal District Court.

www.wlf.org/litigating/case_detail.asp?id=630

On February 22, 2011, the U. S. Supreme Court held that a federal law expressly preempts all state-law products liability suits challenging the design of widely administered childhood vaccines, which the Food and Drug Administration (FDA) has already determined to be safe and effective. The decision was a victory for the ...

www.chegg.com/homework-help/bruesewitz-v-wyeth-llc-compan-y-profile-wyeth-llc-subsidiary-chapter-13-problem-1c-solution-9781285428949-exc

Bruesewitz v. Wyeth, LLC. COMPAN Y PROFILE Wyeth, LLC—a subsidiary of Pfizer, Inc.—is an international pharmaceutical and health-care company with its corporate headquarters in Madison, New Jersey. Wyeth develops, makes, and markets medical therapies, clinical programs, nutritional supplements, prescription ...

www.oyez.org/cases/2010/09-152

Oct 12, 2010 ... Two hours after Hannah Bruesewitz received her six-month diphtheria, tetanus and pertussis vaccine in 1992, she started developing seizures and was hospitalized for weeks. Hannah has continued to suffer from residual seizure disorder that requires her to receive constant care, according to her parents.